A novel antimicrobial peptide Scyreptin
Antimicrobial peptide
Burn wound
Multidrug-resistant bacteria
Pseudomonas aeruginosa
Scyreptin
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
14
09
2023
revised:
30
10
2023
accepted:
09
11
2023
medline:
4
12
2023
pubmed:
13
11
2023
entrez:
12
11
2023
Statut:
ppublish
Résumé
Antimicrobial resistance (AMR) constitutes a significant global threat to human health. In recent years, there has been a concerning surge in infections caused by multidrug-resistant bacteria, highlighting the pressing need to urgently explore novel and effective alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) have emerged as a focal point of research, capturing significant attention as promising antimicrobial agents. In this study, we have identified a novel cationic antimicrobial peptide (AMP) named Scyreptin
Identifiants
pubmed: 37952897
pii: S0006-2952(23)00510-5
doi: 10.1016/j.bcp.2023.115917
pii:
doi:
Substances chimiques
Antimicrobial Peptides
0
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115917Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.